Malaysia targets 2028 to produce its first human vaccine to cut import reliance

AI Summary

Malaysia aims to produce its first locally developed human vaccine by 2028 to reduce reliance on imports. The vaccine will target diseases such as pneumonia, meningitis, sepsis, and blood infections, reflecting a major advancement in public health capabilities.

Malaysia’s first locally produced human vaccine will be for treating illnesses like pneumonia, meningitis, sepsis and blood infections, says Science, Technology and Innovation Minister Chang Lih Kang.